Abiopharma

🔍 Schwening Mateus Scherer (Executive)

Company: StoneCo Ltd. (STNE)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 185,439 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,016,309.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: Represents the acquisition of dividend equivalent rights in the form of additional restricted stock units, which were credited in connection with the Issuer's dividend payment on previously granted restricted stock units awards. These additional restricted stock units are subject to the same terms and conditions, including vesting, as the underlying restricted stock units awards to which they relate.
• F2: The additional restricted stock units were credited at no cash cost to the reporting person as a dividend equivalent on outstanding restricted stock units.
• F3: Includes both restricted stock units that represent a contingent right to receive one share of the Issuer's Common Stock, as well as shares of Common Stock.
• REMARKS: Exhibit 24 - Power of Attorney